Your browser doesn't support javascript.
loading
The serological immunogenicity of the third and fourth doses of COVID-19 vaccine in patients with inflammatory rheumatic diseases on different biologic or targeted DMARDs: a Swedish nationwide study (COVID-19-REUMA).
Frodlund, Martina; Nived, Per; Chatzidionysiou, Katerina; Södergren, Anna; Klingberg, Eva; Hansson, Monica; Ohlsson, Sophie; Pin, Elisa; Bengtsson, Anders; Klareskog, Lars; Kapetanovic, Meliha.
Afiliação
  • Frodlund M; Department of Biomedical and Clinical Sciences, Division of Inflammation and Infection/Rheumatology, Linköping University, Linköping, Sweden.
  • Nived P; Department of Clinical Sciences, Section for Rheumatology, Lund University, Lund and Skåne University Hospital, Lund, Lund, , Sweden.
  • Chatzidionysiou K; Department of Medicine, Rheumatology Unit, Karolinska University Hospital and Karolinska Institutet, Stockholm, Solna, Sweden.
  • Södergren A; Department of Public Health and Clinical Medicine/Rheumatology, Umeå University, Umeå, Sweden.
  • Klingberg E; Department of Rheumatology and Inflammation Research, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Hansson M; Department of Medicine, Rheumatology Unit, Karolinska University Hospital and Karolinska Institutet, Stockholm, Solna, Sweden.
  • Ohlsson S; Department of Clinical Sciences, Section for Nephrology, Lund University, Lund and Skåne University Hospital, Lund, Lund, , Sweden.
  • Pin E; Department of Protein Science, SciLifeLab, KTH Royal Institute of Technology, Stockholm, Sweden.
  • Bengtsson A; Department of Clinical Sciences, Section for Rheumatology, Lund University, Lund and Skåne University Hospital, Lund, Lund, , Sweden.
  • Klareskog L; Department of Medicine, Rheumatology Unit, Karolinska University Hospital and Karolinska Institutet, Stockholm, Solna, Sweden.
  • Kapetanovic M; Department of Clinical Sciences, Section for Rheumatology, Lund University, Lund and Skåne University Hospital, Lund, Lund, , Sweden.
Microbiol Spectr ; 12(4): e0298123, 2024 Apr 02.
Article em En | MEDLINE | ID: mdl-38441463
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Febre Reumática / Antirreumáticos / COVID-19 Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Febre Reumática / Antirreumáticos / COVID-19 Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2024 Tipo de documento: Article